Prestige Brand Holdings Inc Stock News

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TARRYTOWN, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 third quarter earnings release on Thursday, Februar

Prestige Consumer Healthcare Inc (PBH) shares closed today at 1.1% below its 52 week high of $63.83, giving the company a market cap of $3B. The stock is currently up 79.2% year-to-date, up 77.6% over the past 12 months, and up 20.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 57.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 434.2% The company's stock price performance over the past 12 months beats the peer average by 402.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Prestige Consumer Healthcare Inc (PBH) shares closed today at 1.9% below its 52 week high of $63.83, giving the company a market cap of $3B. The stock is currently up 75.1% year-to-date, up 74.9% over the past 12 months, and up 24.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 32.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 455.2% The company's stock price performance over the past 12 months beats the peer average by 471.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -20.6% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.

Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.

Equities analysts forecast that Prestige Consumer Healthcare Inc. (NYSE:PBH) will announce $259.99 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Prestige Consumer Healthcares earnings. The lowest sales estimate is $259.50 million and the highest is $260.48 million. Prestige Consumer Healthcare reported sales of $238.79 million []

Strs Ohio purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 24,000 shares of the companys stock, valued at approximately $1,346,000. Other hedge funds have also modified their holdings of the company. Eagle Bay Advisors []

Prestige Consumer Healthcare In with ticker code (PBH) now have 4 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 72 and 63 calculating the average target price we see 68. Given that the stocks previous close was at 58.99 this is indicating there is a potential upside of 15.3%. The 50 day MA is 59.18 and the 200 moving average now moves to 52.94. The market capitalisation for the company is $2,957m. Find out more information at: https://www.prestigebrands.com [stock_market_widget type="chart" symbol="PBH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody''s analgesic powders, Boudreaux''s Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief.

Wall Street analysts expect Prestige Consumer Healthcare Inc. (NYSE:PBH) to post earnings of $0.89 per share for the current quarter, Zacks reports. Three analysts have made estimates for Prestige Consumer Healthcares earnings. The highest EPS estimate is $0.89 and the lowest is $0.88. Prestige Consumer Healthcare reported earnings of $0.81 per share during the same []

The average age of first pregnancy has increased dramatically worldwide in recent decades, due to a decrease in first births among teenagers and an increase in first births among women over 30 years of age. Increased support for a pregnancy

Head lice are little, wingless, blood-sucking insects that infest in hair. They feed off the blood from your scalp that causes irritation or typically results in huge pimples on the pinnacle. The male lice is far larger in size compared to

Brokerages forecast that Prestige Consumer Healthcare Inc. (NYSE:PBH) will announce sales of $259.99 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Prestige Consumer Healthcares earnings, with estimates ranging from $259.50 million to $260.48 million. Prestige Consumer Healthcare reported sales of $238.79 million in the same quarter last year, []

Foundry Partners LLC purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 169,605 shares of the companys stock, valued at approximately $9,517,000. Several other hedge funds also recently modified []